Lantheus Holdings, Inc.

NasdaqGM:LNTH 株式レポート

時価総額:US$5.6b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Lantheus Holdings マネジメント

マネジメント 基準チェック /44

Lantheus Holdings'の CEO はBrian Markisonで、 Mar2024年に任命され、 の在任期間は 1 年未満です。 は、会社の株式の0.025%を直接所有しており、その価値は$ 1.36M 。経営陣と取締役会の平均在任期間はそれぞれ2年と6.3年です。

主要情報

Brian Markison

最高経営責任者

US$539.1k

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権0.02%
経営陣の平均在職期間2yrs
取締役会の平均在任期間6.3yrs

経営陣の近況

Recent updates

Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus

May 23

Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

May 10
Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

Lantheus Holdings: Powerful First Quarter

May 05

Investors Should Be Encouraged By Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital

Apr 12
Investors Should Be Encouraged By Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital

Lantheus Holdings: Undervalued With A Good Outlook

Feb 28

Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

Feb 24
Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce

Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly

Feb 08
Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly

Market Participants Recognise Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Earnings

Jan 03
Market Participants Recognise Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Earnings

Return Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Appealing

Dec 16
Return Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Appealing

A Look At The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)

Nov 28
A Look At The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)

Is Lantheus Holdings (NASDAQ:LNTH) Using Too Much Debt?

Nov 09
Is Lantheus Holdings (NASDAQ:LNTH) Using Too Much Debt?

Returns At Lantheus Holdings (NASDAQ:LNTH) Appear To Be Weighed Down

Sep 04
Returns At Lantheus Holdings (NASDAQ:LNTH) Appear To Be Weighed Down

Calculating The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)

Aug 09
Calculating The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)

Does Lantheus Holdings (NASDAQ:LNTH) Have A Healthy Balance Sheet?

Jul 22
Does Lantheus Holdings (NASDAQ:LNTH) Have A Healthy Balance Sheet?

Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively

May 29
Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively

Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly

Apr 16
Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly

Capital Allocation Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Ideal

Feb 27
Capital Allocation Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Ideal

An Intrinsic Calculation For Lantheus Holdings, Inc. (NASDAQ:LNTH) Suggests It's 48% Undervalued

Jan 16
An Intrinsic Calculation For Lantheus Holdings, Inc. (NASDAQ:LNTH) Suggests It's 48% Undervalued

Lantheus Holdings (NASDAQ:LNTH) Could Easily Take On More Debt

Dec 24
Lantheus Holdings (NASDAQ:LNTH) Could Easily Take On More Debt

Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively

Oct 31
Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively

Does This Valuation Of Lantheus Holdings, Inc. (NASDAQ:LNTH) Imply Investors Are Overpaying?

Oct 04
Does This Valuation Of Lantheus Holdings, Inc. (NASDAQ:LNTH) Imply Investors Are Overpaying?

Looking In On Lantheus Holdings

Sep 14

Lantheus Holdings a buy at B Riley on growth spurred by approval of imaging agent

Aug 25

Lantheus Non-GAAP EPS of $0.89 beats by $0.19, revenue of $223.72M beats by $19.21M

Aug 04

Lantheus Holdings (NASDAQ:LNTH) May Have Issues Allocating Its Capital

Jul 22
Lantheus Holdings (NASDAQ:LNTH) May Have Issues Allocating Its Capital

Lantheus Holdings Rules The Medical Diagnostics Business World

Jul 06

We Think Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt With Ease

Jun 25
We Think Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt With Ease

CEO(最高経営責任者

Brian Markison (65 yo)

less than a year

在職期間

US$539,112

報酬

Mr. Brian A. Markison has served as Chairman of the Board and Chief Executive Officer of Osmotica Pharmaceutical Corp. since 2016. Mr. Markison had been an Operating Executive and Healthcare Industry Execu...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Brian Markison
CEO & Directorless than a yearUS$539.11k0.025%
$ 1.4m
Paul Blanchfield
President1.3yrsUS$5.31m0.15%
$ 8.2m
Robert Marshall
CFO & Treasurer5.8yrsUS$4.33m0.16%
$ 9.2m
Jean-Claude Provost
Chief Science Officerless than a yearUS$3.08m0.0083%
$ 465.6k
Daniel Niedzwiecki
Chief Administrative Officer3.4yrsUS$3.12m0.12%
$ 6.5m
Andrea Sabens
Chief Accounting Officer2.9yrsデータなし0.091%
$ 5.1m
Dorothy Barr
Senior Vice President of Manufacturing & Technical Operations2yrsデータなしデータなし
Mark Kinarney
Senior Director of Investor Relationsno dataデータなしデータなし
Linda Lennox
VP of Corporate Communications & Chief of Staff3.8yrsデータなしデータなし
Carol Walker
Senior Vice President of Quality6.2yrsデータなしデータなし
Amanda Morgan
Chief Commercial Officer1.6yrsデータなし0.037%
$ 2.1m
Joann Nestor
Senior Vice President of Legal Affairsless than a yearデータなしデータなし

2.0yrs

平均在職期間

57yo

平均年齢

経験豊富な経営陣: LNTHの経営陣は 経験豊富 であると考えられます ( 2年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Brian Markison
CEO & Director11.8yrsUS$539.11k0.025%
$ 1.4m
Samuel Leno
Independent Director12.1yrsUS$493.31k0.087%
$ 4.9m
James Thrall
Independent Director6.3yrsUS$483.39k0.044%
$ 2.5m
Mary Heino
Chairman of the Board8.8yrsUS$12.58m0.91%
$ 51.4m
Minnie Baylor-Henry
Independent Director2.3yrsUS$477.89k0.0043%
$ 244.6k
Gérard Ber
Independent Director4yrsUS$470.81k0.049%
$ 2.8m
Julie McHugh
Lead Independent Director7.4yrsUS$479.11k0.035%
$ 1.9m
Gary John Pruden
Independent Director6.3yrsUS$493.31k0.048%
$ 2.7m
Heinz Mausli
Independent Director4yrsUS$480.00k0.036%
$ 2.0m

6.3yrs

平均在職期間

65yo

平均年齢

経験豊富なボード: LNTHの 取締役会経験豊富 であると考えられます ( 6.3年の平均在任期間)。